08.10.2015 • News

BP to Permanently Close Texas PX unit

BP has announced it will shutter its paraxylene (PX) plant at Texas City in the US with a capacity believed to exceed 1million t/y. The UK-based company cites market conditions as a reason for closing the plant.

BP will continue to operate its two other PX units in the US.

Without providing details the company said that following the closure of the PX facility it plans to reorganize its Texas City Chemicals plant to “better align and scale resources to meet our commitments and support our business goals, while maintaining safe, compliant and reliable operations.”

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read